Yield10 | --- | --- | --- | --- | |------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | Yield10 Bioscience, Inc. NasdaqCM: YTEN | | | | | Investor Presentation | | | | | www.yield10bio.com | | | | | Crop Innovations For Sustainable Food Security | | | | Today March 25, 2021 2 Safe Harbor Statement* The statements made by Yield10 Bioscience, Inc. (the "Company," "we," "our" or "us") herein regarding the Company and its business may be forward-looking in na ...

Yield10 Yield10 Bioscience, Inc. NasdaqCM: YTEN Fourth Quarter and FY 2020 Financial Results and Business Highlights www.yield10bio.com Crop Innovations For Sustainable Food Security Today March 16, 2021 2 Safe Harbor Statement* The statements made by Yield10 Bioscience, Inc. (the "Company," "we," "our" or "us") herein regarding the Company and its business may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-lo ...

Yield10 Bioscience, Inc. (OTCQB:YTEN) Q4 2020 Earnings Conference Call March 16, 2021 4:30 PM ET Company Participants Lynne Brum – Vice President-Planning and Corporate Communications Oliver Peoples – President and Chief Executive Officer Kristi Snell – Vice President of Research and Chief Science Officer Conference Call Participants Anthony Vendetti – Maxim Group Amit Dayal – H.C. Wainwright Ben Klieve – Lake Street Capital Markets Operator Greetings, and welcome to the Fourth Quarter and Full Year 2020 Fi ...

40Use these links to rapidly review the document TABLE OF CONTENTS Index to Consolidated Financial Statements UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware (State or other jurisdiction of incorporation or organization) 04-3158289 (I.R.S. Empl ...

Yield10 Yield10 Bioscience, Inc. NasdaqCM: YTEN Third Quarter 2020 Financial Results and Business Highlights www.yield10bio.com Crop Innovations For Sustainable Food Security Today November 12, 2020 2 Safe Harbor Statement* The statements made by Yield10 Bioscience, Inc. (the "Company," "we," "our" or "us") herein regarding the Company and its business may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking ...

Yield10 Bioscience, Inc. (OTCQB:YTEN) Q3 2020 Earnings Conference Call November 12, 2020 4:30 PM ET Company Participants Lynne Brum - VP, Planning and Corporate Communications Oliver Peoples - President and CEO Kristi Snell - VP, Research and Chief Science Officer Chuck Haaser - Chief Accounting Officer Conference Call Participants Sameer Joshi - H.C. Wainwright Robert LeBoyer - Ladenburg Thalmann Matt Bullock - Maxim Group Operator Welcome to the Third Quarter 2020 Financial Results and Business Update Con ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33133 YIELD10 BIOSCIENCE, INC. (State or other jurisdiction of incorporation or organization) 19 Presidential Way Woburn, MA 01801 (Ad ...

Yield10 Yield10 Bioscience, Inc. (NasdaqCM:YTEN) LD Micro Investor Presentation www.yield10bio.com An agricultural bioscience company developing – "Crop Innovations For Sustainable Food Security" Today September 2, 2020 Safe Harbor Statement* The statements made by Yield10 Bioscience, Inc. (the "Company," "we," "our" or "us") herein regarding the Company and its business may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 19 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-33133 YIELD10 BIOSCIENCE, INC. (State or other jurisdiction of incorporation or organization) 19 Presidential Way Woburn, MA 01801 (Address ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2020 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 19 Presidential Way Woburn, MA 01801 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during ...